Nicergoline EP Impurity C
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

35155-28-3Nicergoline EP Impurity C

● In Stock

Catalogue No.:VL1610002
CAS No.:35155-28-3
Mol. Formula:C18H24N2O2
Mol. Weight:300.4 g/mol

Additional information on CAS 35155-28-3

Parent drug

Nicergoline

IUPAC Name

1,6-Dimethyl-8β-(hydroxymethyl)-10α-methoxyergoline

Synonyms

N/A

Description

Nicergoline EP Impurity C (CAS 35155-28-3) is a structurally defined process-related impurity associated with the semisynthetic ergoline derivative nicergoline. With molecular formula C18H24N2O2 and molecular weight 300.4 g/mol, it belongs to the ergoline alkaloid class and is typically interpreted within impurity profiling as a synthetic intermediate or transformation product arising during side-chain construction or incomplete alkylation chemistry. Its positional and stereochemical relationship to the parent scaffold can complicate chromatographic resolution. Trace determination generally requires high-selectivity reversed-phase LC coupled to MS, often LC-MS/MS, with orthogonal confirmation by NMR where isolation is feasible.

References

SHINTOMI, KEIICHI, et al. “Pharmacological Effects of Nicergoline and Its Metabolites, Decomposition Products and Impurities in Animals.” Journal of Pharmacobio-Dynamics, vol. 10, no. 1, 1987, pp. 35–48, https://doi.org/10.1248/bpb1978.10.35 Winblad, Bengt, et al. “Nicergoline in Dementia.” CNS Drugs, vol. 14, no. 4, Oct. 2000, pp. 267–87, https://doi.org/10.2165/00023210-200014040-00003.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url